Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

China investigates former top healthcare official for bribery

Published 05/27/2015, 07:39 AM
Updated 05/27/2015, 07:39 AM
© Reuters. Flags flutter ahead of the opening session of Chinese People's Political Consultative Conference at Tiananmen Square in Beijing

© Reuters. Flags flutter ahead of the opening session of Chinese People's Political Consultative Conference at Tiananmen Square in Beijing

SHANGHAI (Reuters) - China is investigating the former head of a healthcare ministry unit responsible for drug trials and leading implementation of healthcare policy for bribery, a prosecutor said on Tuesday.

A court in Sichuan province said it was investigating Wang Yu, the former top official at the Bureau of Medical Administration, as part of a crackdown on corruption in the healthcare sector.An official at the health ministry declined to give immediate comment when contacted by telephone while an official at the specific bureau declined to comment. Reuters was unable to reach Wang for comment.

The bureau, part of the National Health and Family Planning Commission, oversees the drafting and implementation of healthcare policy, manages clinical trials and helps supervise the operation of public hospitals.

China's fast-growing healthcare market, the second largest in the world, has been in the spotlight over the last two years with a far-reaching corruption investigation into the drug sector leading to a near $500 million fine against British drugmaker GlaxoSmithKline PLC (L:GSK) last year.

The investigations, part of President Xi Jinping's crackdown on corruption, have thrown an unwelcome spotlight on healthcare executives, doctors and officials. Sources this month said the investigations had started to spread to the medical device sector.

A top health official in the city of Shanghai was sentenced to prison this year after being found guilty of taking bribes, corruption and embezzlement.

© Reuters. Flags flutter ahead of the opening session of Chinese People's Political Consultative Conference at Tiananmen Square in Beijing

China is a magnet for drugmakers, medical device firms and hospital operators, with spending on medicines alone set to hit as much as $185 billion by 2018, according to IMS Health. The country's overall healthcare bill is expected to rise to $1 trillion by 2020, according to McKinsey & Co.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.